Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|November 15, 2011

TAKE Solutions Partners with MENE Research to Capture Emerging Pharma Markets Globally

TAKE Solutions Ltd.

has strengthened its Drug Safety and Pharmacovigilance solutions and services offering to cater to the growing needs of Pharma Emerging nations. The company has partnered with

MENE Research

wherein they together will cater to the Drug Safety requirements of Middle East, Europe, and West Asian countries.

Both the companies together will work towards providing the life science industry with strategy, solutions and services for drug safety operations thus ensuring global regulatory compliance and effective patient safety methodologies is followed. This partnership becomes strong by the fact that TAKE already has to its credit creating a framewokr—SafetyReady—along with a thought leadership in Drug Safety and Pharmacovigilance segments and Mene Research’s regional experience in Middle East, Europe, West Asia, etc.

TAKE Solutions extended Drug Safety and Pharmacovigilance Service Offerings with recent launch of SafetyReady for Oracle Argus Safety Suite Customers. Read

more

.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.